Specifically, MYC oncogene, which is dysregulated in MM due to gene rearrangements or overexpression [40,41,42], is able to induce activation of replicative stress markers with phosphorylation of ATR and replication protein A2 (RPA2/RPA32). Here, MYC is linked to Miyoshi myopathy.